141 results
Page 5 of 8
8-K
EX-5.1
qhj6qmx5da1joh4
7 Sep 18
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
12:00am
8-K
EX-99.1
mdfc3k ds87yih45u
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am
S-3ASR
acm u7ohg2rb9v66
12 Jul 18
Automatic shelf registration
4:30pm
S-3ASR
EX-5.1
y7j zm95wfmk0zb57c6
12 Jul 18
Automatic shelf registration
4:30pm
8-K
EX-99.1
hyau4bav
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-14.1
z4jss1t
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-5.1
o0x5kwy m23s
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
10-K
EX-10.19
tbj40y415 0hwzmlyq
13 Mar 17
Annual report
12:00am